The agency, whose oversight of opioid safety has largely eluded scrutiny, did not improve flawed programs designed to reduce addiction and overdoses.
Published: December 30, 2019 at 05:00PM
from NYT Health https://ift.tt/37jUCig
The agency, whose oversight of opioid safety has largely eluded scrutiny, did not improve flawed programs designed to reduce addiction and overdoses.
Published: December 30, 2019 at 05:00PM
from NYT Health https://ift.tt/37jUCig